Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001811846 | SCV002047988 | uncertain significance | not provided | 2021-03-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001811846 | SCV004534572 | benign | not provided | 2023-07-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004040894 | SCV005001882 | uncertain significance | Inborn genetic diseases | 2024-01-03 | criteria provided, single submitter | clinical testing | The c.2875G>A (p.A959T) alteration is located in exon 21 (coding exon 21) of the PIEZO1 gene. This alteration results from a G to A substitution at nucleotide position 2875, causing the alanine (A) at amino acid position 959 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV001811846 | SCV005193067 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV001811846 | SCV005412552 | uncertain significance | not provided | 2024-07-12 | criteria provided, single submitter | clinical testing | BP4, PM2_moderate |